Volume | 3,469 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 4.7099 | Mínimo Máximo |
|||||
Minimo del Dia | 4.5001 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Aprea Therapeutics Inc | APRE | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
4.7099 | 4.5001 | 4.7099 | 4.5001 | 4.7028 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
149 | 3,469 | US$ 4.58 | US$ 15,872 | - | 2.78 - 8.8465 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
16:30:02 | 25 | US$ 4.51 | USD |
Información Financiera Aprea Therapeutics Inc APRE
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
16.82M | 3.74M | - | 583k | -14.29M | -3.82 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Aprea Therapeutics Inc APRE
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
14/5/2024 | 07:40 | Edgar (US Regulatory) | Form 8-K - Current report |
14/5/2024 | 07:35 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06/2/2024 | 16:01 | Edgar (US Regulatory) | Form 8-K - Current report |
04/2/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
02/2/2024 | 15:26 | Edgar (US Regulatory) | Form 8-K - Current report |
26/1/2024 | 06:13 | Edgar (US Regulatory) | Form 8-K - Current report |
26/1/2024 | 05:03 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
04/1/2024 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
09/11/2023 | 15:20 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
09/11/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
09/11/2023 | 15:10 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
16/10/2023 | 16:29 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos APRE
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.70 | 5.00 | 4.5001 | 4.73 | 6,744 | -0.1999 | -4.25% |
1 Month | 5.48 | 5.90 | 4.5001 | 5.15 | 9,825 | -0.9799 | -17.88% |
3 Months | 5.72 | 6.8799 | 4.5001 | 5.76 | 10,374 | -1.22 | -21.33% |
6 Months | 3.60 | 8.8465 | 3.50 | 6.20 | 22,628 | 0.9001 | 25.00% |
1 Year | 3.70 | 8.8465 | 2.78 | 4.77 | 25,653 | 0.8001 | 21.62% |
3 Years | 95.40 | 156.00 | 2.78 | 79.77 | 608,383 | -90.90 | -95.28% |
5 Years | 309.20 | 1,062.20 | 2.78 | 118.67 | 548,375 | -304.70 | -98.54% |